• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行对化脓性汗腺炎患者的影响。

Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa.

机构信息

Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida, USA.

出版信息

Int Wound J. 2022 Nov;19(7):1686-1692. doi: 10.1111/iwj.13772. Epub 2022 Feb 6.

DOI:10.1111/iwj.13772
PMID:35128802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9111782/
Abstract

The COVID-19 pandemic caused collateral damage to patients with acute and chronic conditions. In this mono-centre cross-sectional study, we sought to evaluate the impact of the COVID-19 pandemic on patients with hidradenitis suppurativa (HS). In June 2020, we sent an anonymous survey to 109 patients, who were diagnosed with HS in our outpatient clinic from May 2018 to April 2020. Fifty patients (45.9%) completed and returned the survey. Forty-five participants (90.0%) denied any cancellation of hospitalisation due to the COVID-19 pandemic. Hospitalisation was postponed in 8% of cases and cancelled in 2%. Compared to prior to the pandemic, fewer patients consulted their primary physician for changing wound dressings and more changed the dressings themselves or were assisted by their family members. 13% of patients avoided doctor visits due to fear of COVID-19 and 26.1% minimised doctor visits. The Dermatology Life Quality Index showed a moderate to very severe impact on patients' Quality of Life (mean score = 10.06). Only one patient used telemedicine. Due to limited access to primary care and fear of COVID-19, the pandemic had a detectable impact on the hospital management of patients with HS in our facility. Telemedicine still plays a negligible role in primary wound care.

摘要

COVID-19 大流行给急性和慢性病患者造成了附带损害。在这项单中心横断面研究中,我们试图评估 COVID-19 大流行对化脓性汗腺炎(HS)患者的影响。2020 年 6 月,我们向 109 名患者发送了一份匿名调查,这些患者于 2018 年 5 月至 2020 年 4 月在我们的门诊被诊断为 HS。有 50 名患者(45.9%)完成并返回了调查。45 名参与者(90.0%)否认因 COVID-19 大流行取消了任何住院治疗。8%的病例推迟了住院治疗,2%的病例取消了住院治疗。与大流行前相比,较少的患者因更换伤口敷料而咨询他们的初级保健医生,更多的患者自己更换敷料或由他们的家庭成员协助。由于担心 COVID-19,13%的患者避免就诊,26.1%的患者尽量减少就诊。皮肤病生活质量指数(Dermatology Life Quality Index)显示,患者的生活质量受到了中等到非常严重的影响(平均得分为 10.06)。只有一名患者使用了远程医疗。由于初级保健服务有限以及对 COVID-19 的恐惧,大流行对我们机构中 HS 患者的医院管理产生了可察觉的影响。远程医疗在初级伤口护理中仍然只发挥了微不足道的作用。

相似文献

1
Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa.COVID-19 大流行对化脓性汗腺炎患者的影响。
Int Wound J. 2022 Nov;19(7):1686-1692. doi: 10.1111/iwj.13772. Epub 2022 Feb 6.
2
Impact of COVID-19 on wound care in Germany.新冠疫情对德国伤口护理的影响。
Int Wound J. 2021 Aug;18(4):536-542. doi: 10.1111/iwj.13553. Epub 2021 Feb 7.
3
Hidradenitis suppurativa perspectives during the COVID-19 pandemic.COVID-19 大流行期间的化脓性汗腺炎展望。
Clin Dermatol. 2023 Sep-Oct;41(5):622-627. doi: 10.1016/j.clindermatol.2023.08.018. Epub 2023 Aug 31.
4
The Impact of Telemedicine on Patients with Hidradenitis Suppurativa in the COVID-19 Era.远程医疗对 COVID-19 时代化脓性汗腺炎患者的影响
Healthcare (Basel). 2023 May 17;11(10):1453. doi: 10.3390/healthcare11101453.
5
Hidradenitis suppurativa patient perspectives during the COVID-19 pandemic.化脓性汗腺炎患者在新冠疫情期间的观点
Dermatol Online J. 2021 Feb 15;27(2):13030/qt42g0634s.
6
The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.加拿大医疗保健专业人员对 COVID-19 大流行期间堕胎服务的看法。
Fam Pract. 2021 Aug 27;38(Suppl 1):i30-i36. doi: 10.1093/fampra/cmab083.
7
Remote consultations for patients with hidradenitis suppurativa during the COVID-19 pandemic: a single-centre experience.新冠疫情期间化脓性汗腺炎患者的远程会诊:单中心经验
Clin Exp Dermatol. 2021 Aug;46(6):1079-1081. doi: 10.1111/ced.14687. Epub 2021 May 21.
8
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy.COVID-19 大流行期间化脓性汗腺炎患者的管理:免疫调节治疗的风险和获益。
Dermatol Ther. 2020 Nov;33(6):e14256. doi: 10.1111/dth.14256. Epub 2020 Sep 14.
9
Anti-COVID-19 measurements for hidradenitis suppurativa patients.防治化脓性汗腺炎患者感染 COVID-19 的措施。
Exp Dermatol. 2021 Jun;30 Suppl 1(Suppl 1):18-22. doi: 10.1111/exd.14339.
10
Cross-Sectional Study Evaluating Clinical & Psychological Impact of Limited Access to Healthcare in Chronic Pain Patients During the COVID-19 Pandemic.在 COVID-19 大流行期间,评估慢性疼痛患者有限获得医疗保健对临床和心理影响的横断面研究。
Pain Physician. 2022 Sep;25(6):427-439.

引用本文的文献

1
[Effects of the COVID-19 pandemic on inpatient dermatosurgery in Germany : Retrospective evaluation of the surgical cases from nine dermatology clinics].[新型冠状病毒肺炎疫情对德国住院皮肤外科手术的影响:对9家皮肤科诊所手术病例的回顾性评估]
Dermatologie (Heidelb). 2024 Nov;75(11):864-877. doi: 10.1007/s00105-024-05417-5. Epub 2024 Oct 10.